The U.S. is likely to begin its widespread booster campaign with only the Pfizer Inc.-BioNTech vaccine, as health regulators seek additional information from Moderna Inc, people familiar said. Moderna …
( read original story …)
The Japan News
The U.S. is likely to begin its widespread booster campaign with only the Pfizer Inc.-BioNTech vaccine, as health regulators seek additional information from Moderna Inc, people familiar said. Moderna …
( read original story …)